Sign Up
Stories
EnteroBiotix Strengthens Executive Team and Raises Funding
Share
Australia's Probiotics Market Growth
Bactolife's Gut Health Breakthrough
Biotech Updates and Market Projections
BioP2P's Matt Gardner Addresses SynBioBe...
Biotech Market Surge: Revenue Forecast
Biotechnology Market Booms Forecast
Overview
API
EnteroBiotix Limited appoints Dr. James Barnes as Chief Operating Officer and Chris Lea as Chief Financial Officer. The company has raised over £25m in funding and is focused on gastrointestinal disease and microbiome therapeutics.
Ask a question
How does EnteroBiotix's focus on microbiome therapeutics differentiate it from other biopharmaceutical companies?
How will Dr. James Barnes' experience benefit EnteroBiotix's drug development and business operations?
What is the significance of the funding raised by EnteroBiotix?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage